Align Technology stock falls after outlook reflects coronavirus concerns 
 Align Technology Inc. ALGN, -2.32% shares fell 3.4% in the extended session Wednesday after the company tempered first-quarter expectations because of the coronavirus threat. The medical device company reported fourth-quarter net income of $121.3 million, or $1.53 a share, compared with $97.4 million, or $1.20 a share, in the year-ago period. Revenue rose to $649.8 million from $534 million in the year-ago period. Analysts surveyed by FactSet had estimated revenue of $646 million. The company said it expects first-quarter earnings of $18.65 to $18.74 a share, including a $17.70 a share for a one-time tax benefit. The company said it expects first-quarter revenue of $615 million to $630 million. Align said that because of coronavirus concerns it is forecasting lower revenue for China, which is the company's largest market and represents about 8% of its total revenue. The company is not aware of any employees "sickened" in the outbreak. Align Technology stock has gained 18% in the past year, with the S&P 500 index SPX, -0.09% rising 24%.